Insmed Incorporated (LON: 0JAV)
London
· Delayed Price · Currency is GBP · Price in USD
79.28
+0.84 (1.08%)
Jan 23, 2025, 2:43 PM BST
Insmed Revenue
Insmed had revenue of $93.43M USD in the quarter ending September 30, 2024, with 18.15% growth. This brings the company's revenue in the last twelve months to $342.96M, up 22.13% year-over-year. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.
Revenue (ttm)
$342.96M
Revenue Growth
+22.13%
P/S Ratio
n/a
Revenue / Employee
$376.05K
Employees
912
Market Cap
11.40B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Insmed News
- 6 days ago - Insider Sell: Roger Adsett Sells 1,457 Shares of Insmed Inc (INSM) - GuruFocus
- 9 days ago - How Is The Market Feeling About Insmed? - Benzinga
- 12 days ago - Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
- 12 days ago - Insmed issues preliminary revenue results, guidance for Arikayce - Seeking Alpha
- 13 days ago - Insmed Inc (INSM) Announces Strong 2024 Financial Results and Strategic Plans for 2025 - GuruFocus
- 13 days ago - Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 14 days ago - Vanguard Group Inc's Strategic Acquisition of Insmed Inc Shares - GuruFocus
- 19 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire